Febrile Neutropenia Market, Global Outlook and Forecast 2023-2028

Report ID: 1134885 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Febrile Neutropenia Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Febrile Neutropenia Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Febrile Neutropenia Overall Market Size
    2.1 Global Febrile Neutropenia Market Size: 2021 VS 2028
    2.2 Global Febrile Neutropenia Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Febrile Neutropenia Players in Global Market
    3.2 Top Global Febrile Neutropenia Companies Ranked by Revenue
    3.3 Global Febrile Neutropenia Revenue by Companies
    3.4 Top 3 and Top 5 Febrile Neutropenia Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Febrile Neutropenia Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Febrile Neutropenia Players in Global Market
        3.6.1 List of Global Tier 1 Febrile Neutropenia Companies
        3.6.2 List of Global Tier 2 and Tier 3 Febrile Neutropenia Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Febrile Neutropenia Market Size Markets, 2021 & 2028
        4.1.2 Pegfilgrastim
        4.1.3 Vancomycin Hydrochloride
        4.1.4 Filgrastim Biosimilars
        4.1.5 Pegfilgrastim Biosimilars
        4.1.6 Others
    4.2 By Type - Global Febrile Neutropenia Revenue & Forecasts
        4.2.1 By Type - Global Febrile Neutropenia Revenue, 2017-2022
        4.2.2 By Type - Global Febrile Neutropenia Revenue, 2023-2028
        4.2.3 By Type - Global Febrile Neutropenia Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Febrile Neutropenia Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Febrile Neutropenia Revenue & Forecasts
        5.2.1 By Application - Global Febrile Neutropenia Revenue, 2017-2022
        5.2.2 By Application - Global Febrile Neutropenia Revenue, 2023-2028
        5.2.3 By Application - Global Febrile Neutropenia Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Febrile Neutropenia Market Size, 2021 & 2028
    6.2 By Region - Global Febrile Neutropenia Revenue & Forecasts
        6.2.1 By Region - Global Febrile Neutropenia Revenue, 2017-2022
        6.2.2 By Region - Global Febrile Neutropenia Revenue, 2023-2028
        6.2.3 By Region - Global Febrile Neutropenia Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Febrile Neutropenia Revenue, 2017-2028
        6.3.2 US Febrile Neutropenia Market Size, 2017-2028
        6.3.3 Canada Febrile Neutropenia Market Size, 2017-2028
        6.3.4 Mexico Febrile Neutropenia Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Febrile Neutropenia Revenue, 2017-2028
        6.4.2 Germany Febrile Neutropenia Market Size, 2017-2028
        6.4.3 France Febrile Neutropenia Market Size, 2017-2028
        6.4.4 U.K. Febrile Neutropenia Market Size, 2017-2028
        6.4.5 Italy Febrile Neutropenia Market Size, 2017-2028
        6.4.6 Russia Febrile Neutropenia Market Size, 2017-2028
        6.4.7 Nordic Countries Febrile Neutropenia Market Size, 2017-2028
        6.4.8 Benelux Febrile Neutropenia Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Febrile Neutropenia Revenue, 2017-2028
        6.5.2 China Febrile Neutropenia Market Size, 2017-2028
        6.5.3 Japan Febrile Neutropenia Market Size, 2017-2028
        6.5.4 South Korea Febrile Neutropenia Market Size, 2017-2028
        6.5.5 Southeast Asia Febrile Neutropenia Market Size, 2017-2028
        6.5.6 India Febrile Neutropenia Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Febrile Neutropenia Revenue, 2017-2028
        6.6.2 Brazil Febrile Neutropenia Market Size, 2017-2028
        6.6.3 Argentina Febrile Neutropenia Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Febrile Neutropenia Revenue, 2017-2028
        6.7.2 Turkey Febrile Neutropenia Market Size, 2017-2028
        6.7.3 Israel Febrile Neutropenia Market Size, 2017-2028
        6.7.4 Saudi Arabia Febrile Neutropenia Market Size, 2017-2028
        6.7.5 UAE Febrile Neutropenia Market Size, 2017-2028
7 Players Profiles
    7.1 Xenetic Biosciences, Inc. (XBIO)
        7.1.1 Xenetic Biosciences, Inc. (XBIO) Corporate Summary
        7.1.2 Xenetic Biosciences, Inc. (XBIO) Business Overview
        7.1.3 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Major Product Offerings
        7.1.4 Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.1.5 Xenetic Biosciences, Inc. (XBIO) Key News
    7.2 Richter Gedeon Nyrt.
        7.2.1 Richter Gedeon Nyrt. Corporate Summary
        7.2.2 Richter Gedeon Nyrt. Business Overview
        7.2.3 Richter Gedeon Nyrt. Febrile Neutropenia Major Product Offerings
        7.2.4 Richter Gedeon Nyrt. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.2.5 Richter Gedeon Nyrt. Key News
    7.3 Amgen Inc.
        7.3.1 Amgen Inc. Corporate Summary
        7.3.2 Amgen Inc. Business Overview
        7.3.3 Amgen Inc. Febrile Neutropenia Major Product Offerings
        7.3.4 Amgen Inc. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.3.5 Amgen Inc. Key News
    7.4 Hospira, Inc.
        7.4.1 Hospira, Inc. Corporate Summary
        7.4.2 Hospira, Inc. Business Overview
        7.4.3 Hospira, Inc. Febrile Neutropenia Major Product Offerings
        7.4.4 Hospira, Inc. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.4.5 Hospira, Inc. Key News
    7.5 Eli Lilly and Company
        7.5.1 Eli Lilly and Company Corporate Summary
        7.5.2 Eli Lilly and Company Business Overview
        7.5.3 Eli Lilly and Company Febrile Neutropenia Major Product Offerings
        7.5.4 Eli Lilly and Company Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.5.5 Eli Lilly and Company Key News
    7.6 USV Private Limited
        7.6.1 USV Private Limited Corporate Summary
        7.6.2 USV Private Limited Business Overview
        7.6.3 USV Private Limited Febrile Neutropenia Major Product Offerings
        7.6.4 USV Private Limited Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.6.5 USV Private Limited Key News
    7.7 Aequus BioPharma, Inc.
        7.7.1 Aequus BioPharma, Inc. Corporate Summary
        7.7.2 Aequus BioPharma, Inc. Business Overview
        7.7.3 Aequus BioPharma, Inc. Febrile Neutropenia Major Product Offerings
        7.7.4 Aequus BioPharma, Inc. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.7.5 Aequus BioPharma, Inc. Key News
    7.8 Taiho Pharmaceutical Co., Ltd.
        7.8.1 Taiho Pharmaceutical Co., Ltd. Corporate Summary
        7.8.2 Taiho Pharmaceutical Co., Ltd. Business Overview
        7.8.3 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Major Product Offerings
        7.8.4 Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.8.5 Taiho Pharmaceutical Co., Ltd. Key News
    7.9 BeyondSpring Inc.
        7.9.1 BeyondSpring Inc. Corporate Summary
        7.9.2 BeyondSpring Inc. Business Overview
        7.9.3 BeyondSpring Inc. Febrile Neutropenia Major Product Offerings
        7.9.4 BeyondSpring Inc. Febrile Neutropenia Revenue in Global Market (2017-2022)
        7.9.5 BeyondSpring Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. Febrile Neutropenia Market Opportunities & Trends in Global Market
    Table 2. Febrile Neutropenia Market Drivers in Global Market
    Table 3. Febrile Neutropenia Market Restraints in Global Market
    Table 4. Key Players of Febrile Neutropenia in Global Market
    Table 5. Top Febrile Neutropenia Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Febrile Neutropenia Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Febrile Neutropenia Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Febrile Neutropenia Product Type
    Table 9. List of Global Tier 1 Febrile Neutropenia Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Febrile Neutropenia Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Febrile Neutropenia Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Febrile Neutropenia Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Febrile Neutropenia Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Febrile Neutropenia Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Febrile Neutropenia Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Febrile Neutropenia Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Febrile Neutropenia Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Febrile Neutropenia Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Febrile Neutropenia Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Febrile Neutropenia Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Febrile Neutropenia Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Febrile Neutropenia Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Febrile Neutropenia Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Febrile Neutropenia Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Febrile Neutropenia Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Febrile Neutropenia Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Febrile Neutropenia Revenue, (US$, Mn), 2023-2028
    Table 30. Xenetic Biosciences, Inc. (XBIO) Corporate Summary
    Table 31. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Product Offerings
    Table 32. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 33. Richter Gedeon Nyrt. Corporate Summary
    Table 34. Richter Gedeon Nyrt. Febrile Neutropenia Product Offerings
    Table 35. Richter Gedeon Nyrt. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 36. Amgen Inc. Corporate Summary
    Table 37. Amgen Inc. Febrile Neutropenia Product Offerings
    Table 38. Amgen Inc. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 39. Hospira, Inc. Corporate Summary
    Table 40. Hospira, Inc. Febrile Neutropenia Product Offerings
    Table 41. Hospira, Inc. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 42. Eli Lilly and Company Corporate Summary
    Table 43. Eli Lilly and Company Febrile Neutropenia Product Offerings
    Table 44. Eli Lilly and Company Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 45. USV Private Limited Corporate Summary
    Table 46. USV Private Limited Febrile Neutropenia Product Offerings
    Table 47. USV Private Limited Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 48. Aequus BioPharma, Inc. Corporate Summary
    Table 49. Aequus BioPharma, Inc. Febrile Neutropenia Product Offerings
    Table 50. Aequus BioPharma, Inc. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 51. Taiho Pharmaceutical Co., Ltd. Corporate Summary
    Table 52. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Product Offerings
    Table 53. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
    Table 54. BeyondSpring Inc. Corporate Summary
    Table 55. BeyondSpring Inc. Febrile Neutropenia Product Offerings
    Table 56. BeyondSpring Inc. Febrile Neutropenia Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Febrile Neutropenia Segment by Type in 2021
    Figure 2. Febrile Neutropenia Segment by Application in 2021
    Figure 3. Global Febrile Neutropenia Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Febrile Neutropenia Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Febrile Neutropenia Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Febrile Neutropenia Revenue in 2021
    Figure 8. By Type - Global Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 12. US Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 16. Germany Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 17. France Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 24. China Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 28. India Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 30. Brazil Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Febrile Neutropenia Revenue Market Share, 2017-2028
    Figure 33. Turkey Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Febrile Neutropenia Revenue, (US$, Mn), 2017-2028
    Figure 37. Xenetic Biosciences, Inc. (XBIO) Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Richter Gedeon Nyrt. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Amgen Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Hospira, Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Eli Lilly and Company Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. USV Private Limited Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Aequus BioPharma, Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Taiho Pharmaceutical Co., Ltd. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. BeyondSpring Inc. Febrile Neutropenia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Febrile Neutropenia Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Febrile Neutropenia Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Febrile Neutropenia Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports